Phase I, Dose-Escalation, Two-Part Trial of the PARP...

  • Main
  • 2017 / 02
  • Phase I, Dose-Escalation, Two-Part Trial of the PARP...
Cancer Discovery 2017 / 02

Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers

de Bono, Johann, Ramanathan, Ramesh K., Mina, Lida, Chugh, Rashmi, Glaspy, John, Rafii, Saeed, Kaye, Stan, Sachdev, Jasgit, Heymach, John, Smith, David C., Henshaw, Joshua W., Herriott, Ashleigh, Patt
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-16-1250
Date:
February, 2017
File:
PDF, 1.36 MB
english, 2017
Conversion to is in progress
Conversion to is failed